Fibromyalgia, Primary
20
5
5
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 20 trials
100.0%
+13.5% vs benchmark
10%
2 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (20)
Pain Phenotypes in Patients With Fibromyalgia Syndrome
Psilocybin-facilitated Treatment for Chronic Pain
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
Preference of Women With Fibromyalgia Undergoing a Three Different Volumes of Resistance Training
Bio-significance of LPC16:0 in Fibromyalgia
Obstructive Sleep Apnea Syndrome and Fibromiyalgia
Effectiveness of Virtual Reality (VR) in Non-oncologic Chronic Musculoskeletal Pain
The Impact of THC on Pain Modulation in Fibromyalgia
Exopulse Mollii Suit and Fibromyalgia
Understanding Health Services Delivery for Fibromyalgia
Balneotherapy in Primary Fibromyalgia
Efficacy of Perineural Injection Therapy in Primary Fibromyalgia
Telehealth Stretching Exercise Program for Women With Fibromyalgia During the Covid-19 Pandemic
Fibromyalgia During the COVID-19 Pandemic
Efficacy of Pregabalin Versus Combined Pregabalin and Milnacipran in Fibromyalgia.
Fibromyalgia Different Approaches: Acupuncture vs Migratens
Mat Pilates Method in the Treatment of Women With Fibromyalgia
The CARRA Registry
An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue
A Study for Adult Patients With Fibromyalgia